Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.44
0.00 (0.00%)
Apr 24, 2026, 4:00 PM EDT - Market closed
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $679.38 million as of April 24, 2026. Its market cap has decreased by -6.96% in one year.
Market Cap
679.38M
Enterprise Value
627.89M
1-Year Change
-6.96%
Ranking
Category
Stock Price
$7.44
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $679.38M, an increase of 31.81%. That is a compound annual growth rate of 11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 679.38M | 5.87% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 771.10M |
| Relmada Therapeutics | 740.51M |
| Forte Biosciences | 730.19M |
| Alpha Tau Medical | 711.12M |
| BridgeBio Oncology Therapeutics | 709.89M |
| Prime Medicine | 701.24M |
| Tenax Therapeutics | 700.18M |
| Arvinas | 679.91M |